The efficacy of third generation anti‑HER2 chimeric antigen receptor T�cells in combination with PD1 blockade against malignant glioblastoma cells-Reference-Cited by-同舟云学术

The efficacy of third generation anti‑HER2 chimeric antigen receptor T�cells in combination with PD1 blockade against malignant glioblastoma cells

Published:2019-08-05 Issue: Volume: Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Shen Luxi¹,Li Hongzhi²,Bin Shufang²,Li Panyuan²,Chen Jie²,Gu Haihua²,Yuan Weihua²

Affiliation:

1. Beijing Friendship Hospital, Capital Medical University, Beijing 100050, P.R. China

2. Key Laboratory of Laboratory Medicine, Ministry of Education, Zhejiang Provincial Key Laboratory of Medical Genetics, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic insights and the clinical prospects of targeted therapies for glioblastoma: a comprehensive review;Experimental Hematology & Oncology;2024-04-13

2. FDA-Approved Chimeric Antigen Receptor (CAR)-T Cell Therapy for Different Cancers-A Recent Perspective;Molecular Biotechnology;2024-03-08

3. Glioblastoma Therapy: Past, Present and Future;International Journal of Molecular Sciences;2024-02-21

4. Current progress of chimeric antigen receptor (CAR) T versus CAR NK cell for immunotherapy of solid tumors;Life Sciences;2024-01

5. Strategies to overcome tumor microenvironment immunosuppressive effect on the functioning of CAR-T cells in high-grade glioma;Therapeutic Advances in Medical Oncology;2024-01